Satellos Bioscience (TSX:MSCL) Accounts Payable : C$1.75 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Accounts Payable?

Satellos Bioscience's Accounts Payable for the quarter that ended in Mar. 2024 was C$1.75 Mil.

Satellos Bioscience's quarterly Accounts Payable increased from Sep. 2023 (C$1.01 Mil) to Dec. 2023 (C$1.04 Mil) and increased from Dec. 2023 (C$1.04 Mil) to Mar. 2024 (C$1.75 Mil).

Satellos Bioscience's annual Accounts Payable increased from Dec. 2021 (C$1.13 Mil) to Dec. 2022 (C$1.47 Mil) but then declined from Dec. 2022 (C$1.47 Mil) to Dec. 2023 (C$1.04 Mil).

Satellos Bioscience Accounts Payable Historical Data

The historical data trend for Satellos Bioscience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Accounts Payable Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable

0.13

1.13

1.47

1.04

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial										1.62	0.76	1.01	1.04	1.75

Satellos Bioscience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Satellos Bioscience Accounts Payable Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines